Work

Abstract PD3-09: Molecular characterization of resistance to antibody drug conjugates in metastatic breast cancer: a prospective analysis from the AURORA US Network

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-pd3-09

Authors: A. C. Garrido-Castro, W. C. Nenad, J. M. Balko, T. Hinoue, G. L. Wheeler, B. J. Kelly, M. Singha, B. M. Felsheim, A. R. Michmerhuizen, U. Chandran, A. V. Lee, L. A. Carey, T. A. King, E. Mardis, P. W. Laird, K. V. Giridhar, K. A. Hoadley, C. M. Perou

Institutions: Dana-Farber Cancer Institute, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Vanderbilt University Medical Center, Van Andel Institute, Nationwide Children's Hospital, Abigail Wexner Research Institute, University of Pittsburgh, Dana-Farber Brigham Cancer Center, Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota)

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129718529

Cites:

Cited by:

Related to: